COX-2 is a novel target in therapy of mycosis fungoides.
Kopp
K L M
KL
Dabelsteen
S
S
Krejsgaard
T
T
Eriksen
K W
KW
Geisler
C
C
Becker
J C
JC
Wasik
M
M
Ødum
N
N
Woetmann
A
A
D000818:Animals; D000068579:Celecoxib; D045744:Cell Line, Tumor; D052246:Cyclooxygenase 2 Inhibitors / Q000627:therapeutic use*; D006801:Humans; D019394:Ki-67 Antigen / Q000032:analysis; D051379:Mice; D009182:Mycosis Fungoides / Q000188:drug therapy*; D011720:Pyrazoles / Q000627:therapeutic use*; D012878:Skin Neoplasms / Q000188:drug therapy*; D013449:Sulfonamides / Q000627:therapeutic use*; D023041:Xenograft Model Antitumor Assays
D052246:Cyclooxygenase 2 Inhibitors; D019394:Ki-67 Antigen; C498355:Mki67 protein, mouse; D011720:Pyrazoles; D013449:Sulfonamides; D000068579:Celecoxib